Newbridge Financial Services Group’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-91
Closed -$11.5K – 1332
2025
Q2
$11.5K Sell
91
-124
-58% -$15.2K ﹤0.01% 850
2025
Q1
$27.5K Sell
215
-34
-14% -$4.61K 0.01% 490
2024
Q4
$32.9K Buy
+249
New +$35K 0.01% 507
2024
Q3
– Sell
-263
Closed -$36.2K – 849
2024
Q2
$36.2K Sell
263
-191
-42% -$25.5K 0.01% 444
2024
Q1
$62.3K Buy
454
+143
+46% +$19.5K 0.03% 359
2023
Q4
$42.3K Sell
311
-77
-20% -$9.39K 0.02% 431
2023
Q3
$47.4K Hold
388
– – 0.02% 423
2023
Q2
$49.3K Buy
388
+84
+28% +$10.9K 0.02% 460
2023
Q1
$39.3K Sell
304
-45
-13% -$5.89K 0.02% 523
2022
Q4
$45.8K Hold
349
– – 0.03% 486
2022
Q3
$41K Buy
349
+40
+13% +$4.97K 0.02% 503
2022
Q2
$36K Hold
309
– – 0.02% 483
2022
Q1
$40K Sell
309
-2,351
-88% -$306K 0.02% 535
2021
Q4
$406K Buy
2,660
+345
+15% +$53.4K 0.19% 109
2021
Q3
$374K Sell
2,315
-50
-2% -$8.41K 0.23% 98
2021
Q2
$387K Sell
2,365
-40
-2% -$6.16K 0.24% 97
2021
Q1
$362K Hold
2,405
– – 0.27% 89
2020
Q4
$364K Sell
2,405
-337
-12% -$48.2K 0.3% 76
2020
Q3
$371K Buy
+2,742
New +$372K 0.37% 63

Other funds holding IBB

Newbridge Financial Services Group's IBB Position: Q3 2025 in Review

Newbridge Financial Services Group sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 91 shares — an estimated $11.5K sold.

Newbridge Financial Services Group first reported a position in IBB in Q3 2020 and held it in 19 quarters. The position peaked at $406K in Q4 2021. 804 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

  • Newbridge Financial Services Group reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
  • Newbridge Financial Services Group sold 91 iShares Biotechnology ETF shares in Q3 2025, an estimated $11.5K.
  • Newbridge Financial Services Group first reported a position in iShares Biotechnology ETF in Q3 2020 and held it in 19 quarters.
  • Newbridge Financial Services Group's iShares Biotechnology ETF position peaked at $406K in Q4 2021.
  • 804 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Newbridge Financial Services Group's 13F filing for Q3 2025, filed 13 Nov 2025.